NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients who have run out of options
Disease control OngoingThis study is testing new combinations of immunotherapy and targeted drugs for adults with B-cell non-Hodgkin's lymphoma that has returned or stopped responding to previous treatments. The main goals are to find safe and effective doses and to see if these combinations can shrink…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for lymphoma patients: testing combination therapies in japan
Disease control OngoingThis study is testing several combinations of a drug called tafasitamab, along with other medications, for Japanese adults with Non-Hodgkin Lymphoma. The main goals are to find safe doses and see how well these combinations work to control the cancer. It includes people whose can…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Scientists collect cancer samples to hunt for future cures
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from people with blood cancers like leukemia and lymphoma. Researchers will study these samples in the lab to better understand how these cancers work. The goal is to find new targets for future treatments and improve detection me…
Matched conditions: NON-HODGKINS LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC